home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Antibody Has Therapeutic Effect on Mice with ALS

 
  April, 9 2010 9:21
your information resource in human molecular genetics
 
     

A biological treatment targeting the protein CD40L has a therapeutic effect on mice with amyotrophic lateral sclerosis (ALS), reports a new study published in Nature Genetics. The study suggests that ALS progression may be amenable to treatments that target the immune response.

ALS is a progressive neurodegenerative disease that leads to neuron loss in the brain and spinal cord and eventual paralysis. ALS affects approximately 2 per 100,000 individuals worldwide and is typically fatal within 5 years of diagnosis.

Steven Perrin and colleagues administered a monoclonal antibody to CD40L to mice with a mutation in SOD1 -- a commonly used mouse model for ALS. They found that the anti-CD40L antibody delayed onset of paralysis and on average, led to a 40% extension of life duration after the first signs of paralysis.

Author contact:

Steven Perrin (ALS Therapy Development Institute, Cambridge, MA, USA)
E-mail: sperrin@als.net

Abstract available online.

(C) Nature Genetics press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.